Skip to content
healthcare.dev

LEVETIRACETAM Extended-release

NDC 81665-101, LEVETIRACETAM, tablet, extended release, from Omnivium Pharmaceuticals LLC.

Product NDC
81665-101
Status
Listed
Labeler
Omnivium Pharmaceuticals LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212688
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81665-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM500 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
81665-101-1281665010112120 TABLET, EXTENDED RELEASE in 1 BOTTLE (81665-101-12)
81665-101-608166501016060 TABLET, EXTENDED RELEASE in 1 BOTTLE (81665-101-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1a31134d-6b63-4d14-8445-0ed132e6c88d

Use it

Look up 81665-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81665-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81665-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.